Results 101 to 110 of about 36,827 (260)
Lymphovascular invasion (LVI) is a recognized predictor of poor postoperative outcomes in patients with esophageal squamous cell carcinoma (ESCC). However, only a few studies have evaluated lymphatic invasion (LI) and venous invasion (VI) separately across contemporary perioperative strategies.
Nao Kitasaki +6 more
wiley +1 more source
ABSTRACT Lentigo maligna (LM) and LM melanoma (LMM) predominantly arise on chronically sun‐damaged head and neck skin and are often considered biologically uniform across facial locations. Whether invasive potential varies by anatomical subsite remains unclear.
Emi Dika +6 more
wiley +1 more source
A Unified Machine Learning Model for Relapse Prediction in Clinical Stage I Testicular Cancer
ABSTRACT Background Approximately one‐fourth of patients with clinical stage I testicular cancer relapse. For decades, risk stratification has been based on different tumor characteristics for seminomas and non‐seminomas. Previous studies primarily used Cox proportional‐hazards models and included only a limited number of variables.
Thomas Wagner +7 more
wiley +1 more source
ABSTRACT Background Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine malignancy with a high risk of nodal metastasis. Sentinel lymph node biopsy (SLNB) is used to stage clinically node‐negative disease and to guide adjuvant therapy decisions.
Julie Ahn +2 more
wiley +1 more source
ABSTRACT Aim The Australian National Bowel Cancer Screening Program began in 2006, offering free faecal occult blood testing every 2 years to Australians aged 50–75 years. We hypothesised a difference in overall survival between screen‐detected and non‐screen‐detected colorectal cancer in an Australian cohort, for each stage I–III.
Michael Rouse +7 more
wiley +1 more source
Treatment strategy and post‐treatment management of colorectal neuroendocrine tumor
Following the increase in colorectal neuroendocrine tumors (NETs), there is a consequent increase in the importance of their appropriate treatment and post‐treatment management.
Masau Sekiguchi +2 more
doaj +1 more source
Long non‐coding RNAs (lncRNAs), a broad class of non‐protein‐coding RNAs, are characterized as new regulators of gene expression at the epigenetic, transcriptional, and post‐transcriptional level. Thus, lncRNAs are involved in the regulation of physiological processes and the development of human diseases and cancer by modulating proinflammatory ...
Charlie Leboff +3 more
wiley +1 more source
Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer
Integrated analysis of 445 bladder cancers showed that HER2 membrane expression and ERBB2 amplification are distinct features. HER2 expression overlapped with NECTIN4 expression, whereas ERBB2 amplification was enriched in the LumU subtype and associated with poor prognosis.
Kensuke Hirosuna +13 more
wiley +1 more source

